
Multiple Myeloma Evolution: Cereblon E3 Ligase Modulators as Next-Generation Therapy in Relapsed/Refractory Disease
Wednesday, March 18, 2026
3:00 p.m. – 4:00 p.m. ET
Please note this TeleECHO program is 3:00 p.m. Eastern, 2:00 p.m. Central, 1:00 p.m. Mountain and 12:00 p.m. Pacific.